Gritstone bio, Inc. (GRTSQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0231
-0.0069 (-23.00%)
Nov 15, 2024, 4:00 PM EST
Gritstone bio Revenue
Gritstone bio had revenue of $921.00K in the quarter ending June 30, 2024, a decrease of -52.89%. This brings the company's revenue in the last twelve months to $14.61M, up 25.09% year-over-year. In the year 2023, Gritstone bio had annual revenue of $16.34M, down -18.05%.
Revenue (ttm)
14.61M
Revenue Growth
+25.09%
P/S Ratio
0.20
Revenue / Employee
63.25K
Employees
231
Market Cap
2.73M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Gritstone bio News
- 6 days ago - Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Bankrupt Gritstone bio in funding talks - Seeking Alpha
- 5 weeks ago - Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna - BNN Bloomberg
- 5 weeks ago - Gritstone bio files for Chapter 11 bankruptcy protection, shares tumble - Seeking Alpha
- 6 weeks ago - Gritstone downgraded by Jones, B. Riley over cancer vaccine data - Seeking Alpha
- 6 weeks ago - Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors' - Benzinga
- 6 weeks ago - Gritstone stock craters 50% in wake of Phase 2 data, corporate update - Seeking Alpha
- 6 weeks ago - Gritstone falls amid Phase 2 Granite data, corporate update - Seeking Alpha